成人急性淋巴细胞白血病初始治疗的优化:向免疫治疗的模式转变 Optimization of upfront therapy for adult acute lymphoblastic leukemia: a paradigm shift toward immunotherapy. PubMed 2025/10/22 发表Med OncolQ2 · IF 4.7(JCR 2025) 人群:儿童人群:成人靶点:CD20技术:CAR-T技术:造血干细胞急性淋巴细胞白血病
急性淋巴细胞白血病(ALL)对 FDA 批准靶向治疗和免疫治疗反应的预测 Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL). PubMed 2024/08/05 发表Curr Treat Options OncolQ1 · IF 5.8(JCR 2025) 人群:儿童人群:成人靶点:CD19靶点:CD20靶点:CD22急性淋巴细胞白血病